On February 21, 2025, the FDA updated its drug shortage list and labeled the shortage of all doses of injectable semaglutide (Ozempic/Wegovy) as being resolved
Stay up to date with all the major news, events and opportunities from the pharmaceutical and medical world by subscribing to my LinkedIn Newsletter here: newsletter.pharmemed.com #obesity #GLP1 #EliLilly #weightloss #pharma Exciting step forward from Lilly
Inside The Holy Weigh, our Christian weight loss program for women, we have many GLP-1 users and walk you step-by-step through navigating these changes
Causal pathways are yet to be fully understood but are considered likely to be multifactorial, including: immune modulation, chronic inflammation, insulin resistance and hormonal imbalance
When an incident occurs, act quickly and methodically to reduce harm and meet compliance obligations